consumer genomics
23andMe Fiscal Q2 Revenues Grow 37 Percent as Firm Leans Into DTC Primary Care Strategy
Telehealth services from the 2021 acquisition of Lemonaid Health fueled much of the growth for 23andMe in the quarter ended Sept. 30.
Saudi Investment Fund Dammam Valley Takes Majority Stake in Arcensus
The investment fund of Imam Abdulrahman bin Faisal University promised to maintain the "autonomy" of German DTC clinical genetic testing startup Arcensus.
The company reported a 9 percent increase in revenues in FY2023 Q1, despite a higher net loss, as it continues to integrate Lemonaid Health.
Nucleus Genomics Acquires Polygenic Risk Score Tool
The New York-based direct-to-consumer startup said it will integrate the Impute.me technology into its in-development genetic analysis platform.
The direct-to-consumer data analysis company faces a tough challenge to realize its mission of becoming a hub for WGS-informed healthcare decision-making.
May 27, 2022
May 3, 2022
LetsGetChecked Completes Acquisition of BioIQ
Feb 18, 2022
Dec 3, 2021
Nov 10, 2021
23andMe Fiscal Q2 Revenues Increase 7 Percent
Apr 22, 2021
Seqster Closes $12M Series A Funding Round
Feb 26, 2021